Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Primary care physician involvement during hospitalisation: a qualitative analysis of perspectives from frequently hospitalised patients.
Bone-Implant Interface
Twist Transcription Factors
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting.
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. Lancet Gastroenterol Hepatol. 2023 09; 8(9):853-859.
View in:
PubMed
subject areas
Consensus
Crohn Disease
Humans
Inflammatory Bowel Diseases
authors with profiles
David T. Rubin